The agency assessed the safety of Ritalin, which is used to treat attention-deficit hyperactivity disorder (ADHD), and other products containing methylphenidate in response to concerns about its cardiovascular safety.
The review concluded that methylphenidate-containing medicines are safe for the treatment of ADHD in patients over six years old.
However, it said that there is a lack of information on the long-term effects of the drug.
‘For patients who take methylphenidate for more than a year, doctors should interrupt treatment at least once a year to determine whether continued treatment with methylphenidate is necessary,’ the agency said.
It also called for additional studies of the long-term effects of the drug to be carried out.
Comment below and tell us what you think